Easton Pharmaceutica Stock Buy Hold or Sell Recommendation

EAPH Stock  USD 0.0001  0.00  0.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Easton Pharmaceutica is 'Strong Sell'. The recommendation algorithm takes into account all of Easton Pharmaceutica's available fundamental, technical, and predictive indicators you will find on this site.
  
Check out Easton Pharmaceutica Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
In addition, we conduct extensive research on individual companies such as Easton and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Easton Pharmaceutica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Execute Easton Pharmaceutica Buy or Sell Advice

The Easton recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Easton Pharmaceutica. Macroaxis does not own or have any residual interests in Easton Pharmaceutica or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Easton Pharmaceutica's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Easton PharmaceuticaBuy Easton Pharmaceutica
Not Rated
For the selected time horizon Easton Pharmaceutica has a Return On Equity of -0.0269, Return On Asset of -0.0083, Current Valuation of 2.14 M, Shares Outstanding of 1.34 B, Price To Earning of (22.00) X and Price To Book of 0 X
We provide trade advice to complement the prevailing expert consensus on Easton Pharmaceutica. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Easton Pharmaceutica is not overpriced, please confirm all Easton Pharmaceutica fundamentals, including its total debt and the relationship between the cash flow from operations and net asset . As Easton Pharmaceutica appears to be a penny stock we also advise to verify its price to sales numbers.

Easton Pharmaceutica Trading Alerts and Improvement Suggestions

Easton Pharmaceutica generated a negative expected return over the last 90 days
Easton Pharmaceutica has some characteristics of a very speculative penny stock
Easton Pharmaceutica has a very high chance of going through financial distress in the upcoming years
Easton Pharmaceutica currently holds 3.28 M in liabilities with Debt to Equity (D/E) ratio of 0.43, which is about average as compared to similar companies. Easton Pharmaceutica has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Easton Pharmaceutica's use of debt, we should always consider it together with its cash and equity.
Net Loss for the year was (188.54 K) with profit before overhead, payroll, taxes, and interest of 201.4 K.
Easton Pharmaceutica currently holds about 5.81 K in cash with (188.54 K) of positive cash flow from operations.
Easton Pharmaceutica has a poor financial position based on the latest SEC disclosures
Latest headline from news.google.com: Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Bloomberg

Easton Pharmaceutica Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash(43.0)156.8K493.0K258K296.7K311.5K
Net Income(245.3K)(169.2K)(323.2K)(188.5K)(216.8K)(227.7K)
Change To Netincome10.9M163.2K434.5K(267.8K)(308.0K)(292.6K)

Easton Pharmaceutica Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Easton Pharmaceutica or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Easton Pharmaceutica's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Easton stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.00
β
Beta against Dow Jones0.00
σ
Overall volatility
0.00
Ir
Information ratio 0.00

Easton Pharmaceutica Volatility Alert

At this time Easton Pharmaceutica exhibits very low volatility. Easton Pharmaceutica appears to be a penny stock. Although Easton Pharmaceutica may be, in fact, a solid short-term or long term investment, many penny stocks are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Easton Pharmaceutica or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Easton instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Easton Pharmaceutica Fundamentals Vs Peers

Comparing Easton Pharmaceutica's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Easton Pharmaceutica's direct or indirect competition across all of the common fundamentals between Easton Pharmaceutica and the related equities. This way, we can detect undervalued stocks with similar characteristics as Easton Pharmaceutica or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Easton Pharmaceutica's fundamental indicators could also be used in its relative valuation, which is a method of valuing Easton Pharmaceutica by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Easton Pharmaceutica to competition
FundamentalsEaston PharmaceuticaPeer Average
Return On Equity-0.0269-0.31
Return On Asset-0.0083-0.14
Current Valuation2.14 M16.62 B
Shares Outstanding1.34 B571.82 M
Price To Earning(22.00) X28.72 X
Price To Book0 X9.51 X
Price To Sales0.06 X11.42 X
Gross Profit201.4 K27.38 B
EBITDA(188.54 K)3.9 B
Net Income(188.54 K)570.98 M
Cash And Equivalents5.81 K2.7 B
Total Debt3.28 M5.32 B
Debt To Equity0.43 %48.70 %
Current Ratio0.69 X2.16 X
Book Value Per Share0.01 X1.93 K
Cash Flow From Operations(188.54 K)971.22 M
Beta15.58-0.15
Market Capitalization134.49 K19.03 B
Total Asset10.19 M29.47 B
Retained Earnings(39.82 M)9.33 B
Working Capital(194.5 K)1.48 B
Current Asset297 K9.34 B
Current Liabilities137 K7.9 B
Net Asset10.19 M

Easton Pharmaceutica Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Easton . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Easton Pharmaceutica Buy or Sell Advice

When is the right time to buy or sell Easton Pharmaceutica? Buying financial instruments such as Easton Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Easton Pharmaceutica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Pharmaceutical Products Thematic Idea Now

Pharmaceutical Products
Pharmaceutical Products Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock:
Check out Easton Pharmaceutica Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.001
Return On Assets
(0.01)
Return On Equity
(0.03)
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.